Epidemiology and prevention of prostate cancer

G Gandaglia, R Leni, F Bray, N Fleshner… - European urology …, 2021 - Elsevier
Abstract Context Worldwide, prostate cancer (PCa) represents the second most common
solid tumor in men. Objective To assess the geographical distribution of PCa …

Epidemiology and genomics of prostate cancer in Asian men

Y Zhu, M Mo, Y Wei, J Wu, J Pan, SJ Freedland… - Nature Reviews …, 2021 - nature.com
Prostate cancer is a global health problem, but incidence varies considerably across
different continents. Asia is traditionally considered a low-incidence area, but the incidence …

Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression

C Xue, G Li, J Lu, L Li - Signal transduction and targeted therapy, 2021 - nature.com
Circular RNAs (circRNAs), covalently closed noncoding RNAs, are widely expressed in
eukaryotes and viruses. They can function by regulating target gene expression, linear RNA …

Multiparametric MRI for prostate cancer diagnosis: current status and future directions

A Stabile, F Giganti, AB Rosenkrantz, SS Taneja… - Nature reviews …, 2020 - nature.com
The current diagnostic pathway for prostate cancer has resulted in overdiagnosis and
consequent overtreatment as well as underdiagnosis and missed diagnoses in many men …

Biomarkers for prostate cancer: prostate-specific antigen and beyond

MJ Duffy - Clinical Chemistry and Laboratory Medicine (CCLM), 2020 - degruyter.com
In recent years, several new biomarkers supplementing the role of prostate-specific antigen
(PSA) have become available for men with prostate cancer. Although widely used in an ad …

The impact of the COVID-19 pandemic and the associated Belgian governmental measures on cancer screening, surgical pathology and cytopathology

MC De Pelsemaeker, Y Guiot, J Vanderveken… - Pathobiology, 2021 - karger.com
Introduction: The severe acute respiratory syndrome coronavirus 2 caused a pandemic of
coronavirus disease 2019 (COVID-19). Unprecedented public health actions were …

[HTML][HTML] Prostate-specific antigen screening in transgender patients

F Nik-Ahd, A Jarjour, J Figueiredo, JT Anger, M Garcia… - European Urology, 2023 - Elsevier
Abstract Context Approximately 0.4–1.3% of the worldwide population is transgender.
Although the exact prevalence is unknown, there is an increase in open identification as …

French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease

G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022 - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Clinical usefulness of circulating tumor markers

X Filella, M Rodríguez-Garcia… - Clinical Chemistry and …, 2023 - degruyter.com
Tumor markers are a heterogeneous group of substances released by cancer cells into
bloodstream, but also expressed by healthy tissues. Thus, very small concentrations can be …

Verification of harmonization of serum total and free prostate-specific antigen (PSA) measurements and implications for medical decisions

S Ferraro, M Bussetti, S Rizzardi, F Braga… - Clinical …, 2021 - academic.oup.com
Background Previous studies have shown that the harmonization of prostate-specific
antigen (PSA) assays remained limited even after the introduction of WHO International …